Portal de investigación
Who really benefits from chemotherapy in high-risk localized soft tissue sarcoma? A virtual twin analysis of ISG-STS 1001
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Dossa, F
- Callegaro, D
- Palmerini, E
- Quagliuolo, V
- Martin-Broto, J
- Grignani, G
- Brunello, A
- Blay, JY
- Ferraresi, V
- Lugowska, IA
- Pizzamiglio, S
- Verderio, P
- Palassini, E
- Bianchi, G
- Stacchiotti, S
- Bague, S
- Coindre, JM
- Dei Tos, AP
- Gronchi, A
Grupos
Abstract
Abstract no disponible
Datos de la publicación
- ISSN/ISSNe:
- 0732-183X, 1527-7755
- Tipo:
- Meeting Abstract
- Páginas:
- -
- Factor de Impacto:
- 9,378 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
JOURNAL OF CLINICAL ONCOLOGY LIPPINCOTT WILLIAMS & WILKINS
Documentos
- No hay documentos
Filiaciones
Filiaciones no disponibles
Cita
Dossa,F,Callegaro,D,Palmerini,E,Quagliuolo,V,Martin,J,Grignani,G,Brunello,A et al. Who really benefits from chemotherapy in high-risk localized soft tissue sarcoma? A virtual twin analysis of ISG-STS 1001. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). 2026. Chicago. TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103:LIPPINCOTT WILLIAMS & WILKINS. 2026 p.11573.